 To evaluate the safety and efficacy of the Complete SE SFA Stent System in the treatment of de novo andor restenotic lesions or occlusions in the Superficial Femoral Artery SFA andor Proximal Popliteal Artery PPA in subjects with symptomatic Peripheral Artery Disease PAD. 